Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Molecular Pharmacology

• Publication date

  2002-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/MOL.62.1.1PMID 12065748
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels.

  2002cited by this paper
• Molecular determinants of intracellular pH modulation of human Kv1.4 N-type inactivation.

  2002cited by this paper
• Mechanisms of cancer drug resistance.

  2002cited by this paper
• ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.

  2001cited by this paper
• MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.

  2001cited by this paper
• Frequency of C3435T polymorphism of MDR1 gene in African people.

  2001cited by this paper
• Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy.

  2001cited by this paper
• The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.

  2001cited by this paper
• HMG‐CoA reductase inhibitors and P‐glycoprotein modulation

  2001cited by this paper
• Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects

  2001influential reference
• Identification of functionally variant MDR1 alleles among European Americans and African Americans

  2001cited by this paper
• A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans.

  2001cited by this paper
• Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects.

  2001cited by this paper
• A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P‐glycoprotein

  2000cited by this paper
• P-Glycoprotein and Bioavailability-Implication of Polymorphism

  2000cited by this paper
• Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

  2000influential reference
• A family of drug transporters: the multidrug resistance-associated proteins.

  2000cited by this paper
• Functional Characterization of Glycosylation-Deficient Human P-Glycoprotein Using A Vaccinia Virus Expression System

  2000influential reference
• Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

  1999cited by this paper
• The multidrug resistance protein family.

  1999cited by this paper
• Recombinant vaccinia virus vectors for functional expression of P-glycoprotein in mammalian cells.

  1998influential reference
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

  1998cited by this paper
• Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors.

  1998cited by this paper
• HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

  1998cited by this paper
• Functional expression of human P-glycoprotein from plasmids using vaccinia virus-bacteriophage T7 RNA polymerase system.

  1998influential reference
• Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.

  1998cited by this paper
• Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.

  1997cited by this paper
• Substantial excretion of digoxin via the intestinal mucosa and prevention of long‐term digoxin accumulation in the brain by the mdrla P‐glycoprotein

  1996cited by this paper
• Characterization of Phosphorylation-defective Mutants of Human P-glycoprotein Expressed in Mammalian Cells (*)

  1996cited by this paper
• Genetic analysis of the multidrug transporter.

  1995cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper
• Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

  1989cited by this paper
• A polymorphic HindIII site within the human multidrug resistance gene 1 (MDR1).

  1988cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1987cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1985cited by this paper

• In vitro identification of decreased function genetic variants of ABCB1.

  2025cites this paper
• Mapping the Role of P-gp in Multidrug Resistance: Insights from Recent Structural Studies

  2025cites this paper
• Regulation of P-Glycoprotein during Oxidative Stress

  2024cites this paper
• Pharmacogenomics and Personalized Medicine

  2024cites this paper
• Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer

  2024cites this paper
• Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.

  2023cites this paper
• Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab

  2023cites this paper
• Toxicity and therapy outcome associations in LIG3, SLCO1B3, ABCB1, OPRM1 and GSTP1 in high‐grade serous ovarian cancer

  2023cites this paper
• Ethnogeographic and inter-individual variability of human ABC transporters

  2020cites this paper
• The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review

  2020cites this paper
• A combination of clioquinol, zinc and copper increases the abundance and function of breast cancer resistance protein in human brain microvascular endothelial cells.

  2020cites this paper
• MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease

  2018cites this paper
• CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose‐adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post‐Kidney Transplantation

  2018cites this paper
• Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants

  2018cites this paper
• Multixenobiotic resistance in Mytilus edulis: Molecular and functional characterization of an ABCG2- type transporter in hemocytes and gills.

  2018cites this paper
• Analysis of US FDA-Approved Drugs Containing Sulfur Atoms

  2018cites this paper
• Computational Pharmacogenetics of P-Glycoprotein Mediated Antiepileptic Drug Resistance

  2018cites this paper
• Polymorphisms of genes related to metotrexate response and toxicity in high-grade osteosarcoma

  2017cites this paper
• Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease

  2017cites this paper
• Pharmacogenetics and Metabolic Disease

  2016cites this paper
• Computational Studies of P-Glycoprotein Polymorphisms in Antiepileptic Drug Resistance Mechanisms

  2016influential citation
• Genetic Polymorphisms of P-glycoprotein: Echoes of Silence

  2016cites this paper
• Pharmacogenetics of Respiratory Disease

  2016cites this paper
• THE IMPACT OF ABCB 1 ( C 3435 T ) POLYMORPHISM ON THE EFFICACY OF ONDANSETRON FOR POST-OPERATIVE NAUSEA AND VOMITING IN PAKISTANI POPULATION

  2016cites this paper
• Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma

  2016cites this paper
• Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation.

  2015cites this paper
• Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation

  2015cites this paper
• MDR 1 ( ABCB 1 ) polymorphisms : functional effects and clinical implications

  2014cites this paper
• Targeting CNS transporters for treatment of neurodegenerative diseases.

  2014cites this paper
• Pharmacogenetics of membrane transporters: a review of current approaches.

  2014cites this paper
• Transport in technicolor: Mapping ATP‐binding cassette transporters in sea urchin embryos

  2014cites this paper
• Pharmacogenomics of methadone maintenance treatment.

  2014cites this paper
• Association of a multidrug resistance 1 gene polymorphism and colorectal cancer in the Korean population

  2013cites this paper
• The Pharmacogenomics of Membrane Transporters Project

  2013cites this paper
• ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro

  2013cites this paper
• MDR1 (ABCB1) polymorphisms: functional effects and clinical implications.

  2013cites this paper
• MDR1 polymorphisms are associated with inflammatory bowel disease in a cohort of Croatian IBD patients

  2013cites this paper
• Influence of CYP3A enzymes and ABC transporters on the activity of tyrosine kinase inhibitors in chronic myeloid leukemia

  2013cites this paper
• P‐glycoprotein (MDR1/ABCB1)

  2013cites this paper
• CYP 3 A activity influences imatinib response in patients with chronic myeloid leukemia : a pilot study on in vivo CYP 3 A activity

  2013cites this paper
• Assessment of Drug Transporter Function Using Fluorescent Cell Imaging

  2013influential citation
• MEASUREMENT OF TRANSPORTER FUNCTION IN CELLS OVEREXPRESSING AN ABC TRANSPORTER USING AN AUTOMATED FLUORESCENT

  2013influential citation
• Mitochondria-targeted Doxorubicin is Active and Resistant to Drug Efflux

  2012cites this paper
• Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity.

  2012cites this paper
• Localization and Substrate Selectivity of Sea Urchin Multidrug (MDR) Efflux Transporters*

  2012cites this paper
• Pharmacogenetics of Drug Transporters

  2012cites this paper
• Blood–brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene

  2012cites this paper
• ABC Drug Transporters and Their Impact on Drug Disposition/Drug Sensitivity and Resistance

  2012cites this paper
• Rapid detection of ABC transporter interaction: potential utility in pharmacology.

  2011cites this paper
• Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes

  2011cites this paper
• Relationship between P-glycoprotein and second-generation antipsychotics.

  2011cites this paper
• An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics

  2011cites this paper
• Pharmacogenetics of genes across the doxorubicin pathway

  2011cites this paper
• P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations.

  2011cites this paper
• Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.

  2011cites this paper
• Pharmacogenetics of antidepressant response

  2011cites this paper
• Different Transport Activity of Human Triallelic MDR1 893Ala/Ser/Thr Variant and its Association with Herb Extracts

  2011cites this paper
• mdr-1 SNPs in Ovarian Cancer Tissue - G2677T/A Correlates with Response to Paclitaxel Chemotherapy

  2010cites this paper
• Pharmacogenetics of ATP-binding cassette transporters and clinical implications.

  2010cites this paper
• Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

  2010cites this paper
• Domperidone Treatment for Gastroparesis: Demographic and Pharmacogenetic Characterization of Clinical Efficacy and Side-Effects

  2010cites this paper
• Determination of the absolute configurations of synthetic daunorubicin analogues using vibrational circular dichroism spectroscopy and density functional theory.

  2010cites this paper
• Drug transporter pharmacogenetics in nucleoside-based therapies.

  2010cites this paper
• Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

  2010cites this paper
• Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype

  2010cites this paper
• Interactions of Flavones and Related Compounds with Nucleic Acids

  2009cites this paper
• Intracellular trafficking of MDR transporters and relevance of SNPs.

  2009cites this paper
• ABC transporters as potential targets for modulation of drug resistance.

  2009cites this paper
• A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.

  2009cites this paper
• Synthesis and DNA-binding affinity studies of glycosylated intercalators designed as functional mimics of the anthracycline antibiotics.

  2009cites this paper
• Multidrug Resistance Protein ( P-Glycoprotein ; MDR 1 )

  2009cites this paper
• Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer

  2009cites this paper
• Transplacental Pharmacokinetics of Glyburide, Rhodamine 123, and BODIPY FL Prazosin: Effect of Drug Efflux Transporters and Lipid Solubility

  2009cites this paper
• Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer.

  2009cites this paper
• ROLES OF SULFOTRANSFERASE ENZYMES IN TRANS-PLACENTAL DISPOSITION

  2009cites this paper
• Chemotherapy in the Pediatric Patient

  2009cites this paper
• Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease

  2009cites this paper
• Selectable Markers for Gene Therapy

  2008cites this paper
• Pharmacogenetics of membrane transporters: a review of current approaches.

  2008cites this paper
• Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms

  2008influential citation
• Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients

  2008cites this paper
• ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel.

  2008cites this paper
• ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy

  2008cites this paper
• A Novel Human Multidrug Resistance Gene MDR1 Variant G571A (G191R) Modulates Cancer Drug Resistance and Efflux Transport

  2008cites this paper
• Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs.

  2008cites this paper
• Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs

  2008cites this paper
• ABC multidrug transporters: structure, function and role in chemoresistance.

  2008cites this paper
• ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research

  2007influential citation
• Overlapping ligand specificity of P-glycoprotein and serum alpha(1)-acid glycoprotein: evidences and potential implications.

  2007cites this paper
• A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity

  2007cites this paper
• Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans

  2007cites this paper
• Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regions

  2007cites this paper
• Simultaneously targeting hypoxic cancer cells by hsp90 inhibitor and glycolysis inhibitor in pancreatic cancer therapy

  2007cites this paper
• Sequential Influences of Leukemia-Specific and Genetic Factors on P-Glycoprotein Expression in Blasts from 817 Patients Entered into the National Cancer Research Network Acute Myeloid Leukemia 14 and 15 Trials

  2007cites this paper
• Pharmacogenetic Studies of Paclitaxel in Ovarian Cancer : focus on interindividual differences in pharmacodynamics and pharmacokinetics

  2007cites this paper
• N-Glycolyl GM 1 Ganglioside as a Receptor for Simian Virus 40 †

  2007cites this paper
• N-Glycolyl GM1 Ganglioside as a Receptor for Simian Virus 40

  2007cites this paper
• Function-Altering SNPs in the Human Multidrug Transporter Gene ABCB1 Identified Using a Saccharomyces-Based Assay

  2007cites this paper
• MDR1 gene polymorphisms and clinical relevance.

  2006cites this paper
• mdr-1 Single Nucleotide Polymorphisms in Ovarian Cancer Tissue: G2677T/A Correlates with Response to Paclitaxel Chemotherapy

  2006cites this paper